pcDNA3.1 SARS-CoV-2 S D614G Citations (6)
Originally described in: Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J Cell. 2020 Sep 15. pii: S0092-8674(20)31229-0. doi: 10.1016/j.cell.2020.09.032. PubMed Journal
Articles Citing pcDNA3.1 SARS-CoV-2 S D614G
| Articles |
|---|
| Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis. Satta S, Lai A, Cavallero S, Williamson C, Chen J, Blazquez-Medela AM, Roustaei M, Dillon BJ, Ashammakhi N, Carlo DD, Li Z, Sun R, Hsiai TK. Adv Sci (Weinh). 2021 Dec;8(23):e2103266. doi: 10.1002/advs.202103266. Epub 2021 Oct 23. PubMed |
| Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity. Du K, Sun L, Luo Z, Cao Y, Sun Q, Zhang K, Faizy A, Piomelli D, Lu X, Shan J, Yang Q. Metabolism. 2022 Jun;131:155181. doi: 10.1016/j.metabol.2022.155181. Epub 2022 Mar 18. PubMed |
| SARS-CoV-2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice. Ma Y, Wang Y, Dong C, Gonzalez GX, Zhu W, Kim J, Wei L, Kang SM, Wang BZ. Small. 2022 Jun;18(25):e2200836. doi: 10.1002/smll.202200836. Epub 2022 May 23. PubMed |
| Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer. Kim J, Jeong J, Lee CM, Lee DW, Kang CK, Choe PG, Kim NJ, Oh MD, Lee CH, Park WB, Lee KH, Im SA. Front Immunol. 2022 Nov 17;13:1028102. doi: 10.3389/fimmu.2022.1028102. eCollection 2022. PubMed |
| An integrated signaling threshold initiates IgG response towards virus-like immunogens. Wholey WY, Meyer AR, Yoda ST, Mueller JL, Mathenge R, Chackerian B, Zikherman J, Cheng W. bioRxiv [Preprint]. 2024 Jan 31:2024.01.28.577643. doi: 10.1101/2024.01.28.577643. PubMed |
| Minimal Determinants for Lifelong Antiviral Antibody Responses in Mice from a Single Exposure to Virus-like Immunogens at Low Doses. Wholey WY, Meyer AR, Yoda ST, Chackerian B, Zikherman J, Cheng W. Vaccines (Basel). 2024 Apr 11;12(4):405. doi: 10.3390/vaccines12040405. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.